Hopp til innhold

Vitenskapelige publikasjoner om svineinfluensa-pandemien i 2009

Publisert Oppdatert


Litteraturlisten viser publisert forskning fra FHI etter pandemien med svineinfluensa (A(H1N1)) i 2009-2010.


(33)
Kristian Waalen, Anette Kilander, Susanne G Dudman, Remilyn Ramos-Ocao, and Olav Hungnes
Age dependent prevalence of antibody cross-reactive to influenza A(H3N2) variant virus in sera collected in 2011 – Norway. Euro Surveill. http://www.eurosurveillance.org/images/dynamic/EE/V17N19/art20170.pdf

(32 )
Vaksinasjon mot pandemisk influensa 2009 (brev)
Stene-Larsen G. Tidsskr Nor Legeforen http://tidsskriftet.no/article/2246011

(31 )
Characterization in vitro and in vivo of pandemic (H1N1) 2009 viruses isolated from patients
Watanabe T, Imai1 M, Watanabe S, Shinya K, Hatta M, Li C, Wolter BF, Neumann G, Ozawa M, Hanson A, Zhong G, Fukuyama S, Simmons HA, Schenkman D, Brunner K, Capuano III SV, Weinfurter JT, Kilander A, Dudman SG, Suresh M, Hungnes O, Friedrich TC, Kawaoka Y.
J Virol http://www.ncbi.nlm.nih.gov/pubmed/22718834

(29)
Estimating influenza-related sick leave in Norway: Was work absenteeism higher during the 2009 A(H1N1) pandemic compared to seasonal epidemics?
De Blasio BF, Gran JM, Xue Y, Iversen B, Swärd J
Eurosurveillance http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20246

(27)
Usefulness of health registries when estimating vaccine effectiveness during the influenza A(H1N1) 2009 pandemic in Norway. Herrador BG, Aavitsland P, Feiring B, Bergsaker MAR, Borgen K. BMC Infect Dis
http://www.biomedcentral.com/content/pdf/1471-2334-12-63.pdf  

(26)
Pneumonia caused by influenza A H1N1 2009 virus in farmed American mink (Neovison vison)
Åkerstedt J, Valheim M, Germundsson A, Moldal T, Lie KI, Falk M, Hungnes O
Vet Rec http://veterinaryrecord.bmj.com/content/170/14/362.2.extract

(25)
Experiences after Twenty Months with Pandemic Influenza A (H1N1) 2009 Infection in the Naïve Norwegian Pig Population.
Gjerset B, Er C, Løtvedt S, Jørgensen A, Hungnes O, Lium B, Germundsson A.
Influenza Research and Treatment  http://www.hindawi.com/journals/irt/2011/206975/cta/

24
Fertility fluctuations in times of war and pandemic influenza (letter)
Mamelund SE. J Infect Dis http://jid.oxfordjournals.org/cgi/reprint/jis315? ijkey=HpgvUdwIQ0rwxjM&keytype=ref 

23
Effect of vaccines and antivirals during the major 2009 A(H1N1) pandemic wave in Norway - and the influence of vaccination timing de Blasio BF, Iversen B, Tomba GS. PloS ONE 2012: 7: e30018 (http://www.ncbi.nlm.nih.gov/pubmed/22253862)

22
Antiviral resistance during the A(H1N1) 2009 influenza pandemic: public health, laboratory, and clinical perspectives
Hurt AC, Chotpitayasunondh T, Cox NJ, Daniels R, Fry AM, Gubareva LV, Hayden FG, Hui DS, Hungnes O, Lackenby A, Lim W, Meijer A, Penn C, Tashiro M, Uyeki TM, Zambon M; on behalf of the WHO Consultation on Pandemic Influenza A (H1N1) 2009 Virus Resistance to Antivirals
Lancet Infect Dis 2012; 12: 240-8. (http://www.ncbi.nlm.nih.gov/pubmed/22186145)

21
Rituximab monotherapy or combined with chemotherapy blocks protective serological response to the pandemic influenza A(H1N1) 2009 vaccine in lymphoma patients. Yri EO, Torfoss D, Waalen K, Dudman SG, Kilander A, Hungnes O, Østenstad B, Ekanger R, Meyer P, Wader KF, Kolstad A. Blood 2011; 118: 6769-71 (http://www.ncbi.nlm.nih.gov/pubmed/22058114)

20
Avian-type receptor-binding ability enhances influenza virus pathogenicity in macaques
Watanabe T, Shinya K [ca 30 flere] Wang J, Kilander A, Dudman SG, Suresh M, Mason RJ, Hungnes O, Friedrich TC, Kawaoka Y J Virol 2011; 85: 13195-203. (http://www.ncbi.nlm.nih.gov/pubmed/21937653)


19
Vaccine history, gender and influenza vaccination in a household context Mamelund S-E, Bergsaker MAB.
Vaccine 2011; 29: 9441-50. (http://www.ncbi.nlm.nih.gov/pubmed/22027482)

18
Pandemien i Austevoll (brev) Aavitsland P, Iversen B, Nøkleby H. Tidsskr Nor Legeforen 2011; 131: 1180 (http://www.ncbi.nlm.nih.gov/pubmed/21694740)


17
Geography may explain adult mortality from the 1918–20 influenza pandemic Mamelund S-E
Epidemics 2011; 3: 46-60 (http://www.ncbi.nlm.nih.gov/pubmed/21420659)

16
Feilinformert om influensaserologi (brev) Vik IS, Dudman SG, Hungnes O, Hoddevik G.
Tidsskr Nor Legeforen 2011; 131:110-1 (http://www.ncbi.nlm.nih.gov/pubmed/21267019)

15
Standardization and validation of assays determining cellular immune responses against influenza.
Gijzen K, Liu WM, Visontai I, Oftung F, van der Werf S, Korsvold GE, Pronk I, Aaberge IS, Tütto A, Jankovics I, Jankovics M, Gentleman B, McElhaney JE, Soethout EC. Vaccine 2010; 28: 3416-22 (http://www.ncbi.nlm.nih.gov/pubmed/20206285)

14
Initial surveillance of 2009 influenza A(H1N1) pandemic in the European Union and European Economic Area, April-September 2009. Devaux I, Kreidl P, Penttinen P, Salminen M, Zucs P, Ammon A; ECDC influenza surveillance group; national coordinators for influenza surveillance*. (inkl Borgen K, Dudman S, Hauge SH, Hungnes O, Kilander A, Aavitsland P) Euro Surveill 2010; 15 pii: 19740. (http://www.ncbi.nlm.nih.gov/pubmed/21163182)

13
High prevalence of antibodies to the 2009 pandemic influenza A(H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009.


Waalen K, Kilander A, Dudman SG, Krogh GH, Aune T, Hungnes O.
Euro Surveill 2010; 15 pii: 19633. (http://www.ncbi.nlm.nih.gov/pubmed/20738992)

12
Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009-2010 Kilander A, Rykkvin R, Dudman SG, Hungnes O.
Euro Surveill 2010; 15 pii: 19498. (http://www.ncbi.nlm.nih.gov/pubmed/20214869)

11
Meldte bivirkninger av pandemivaksinen. Pandemrix i Norge. Madsen S, Andersen SR, Bergsaker MAR,
Buajordet I, Ege MS, Harg P, Lavoll SB, Storsæter J, Syvertsen C. Utposten 2010; 29: 31-5. (http://www.utposten-stiftelsen.no/Portals/14/Utposten10/UP10_05/31_35_pandemrix_Utp_5_2010w.pdf)

10
Estimating influenza-related excess mortality and reproduction numbers for seasonal influenza in Norway, 1975-2004.
Gran JM, Iversen B, Hungnes O, Aalen OO. Epidemiol Infect 2010; 138: 1559-68. (http://www.ncbi.nlm.nih.gov/pubmed/20334732)

9
Oseltamivir-resistant influenza A(H1N1) viruses detected in Europe during season 2007-8 had epidemiologic and clinical characteristics similar to co-circulating susceptible A(H1N1) viruses. Ciancio BC, Meerhoff TJ, Kramarz P, Bonmarin I, Borgen K, Boucher CA, Buchholz U, Buda S, Dijkstra F, Dudman S, Duwe S, Hauge SH, Hungnes O, Meijer A, Mossong J, Paget WJ, Phin N, van der Sande M, Schweiger B, Nicoll A. Euro Surveill 2009; 14 pii: 19412. (http://www.ncbi.nlm.nih.gov/pubmed/19941797)

8
Clinical efficiency after one dose of Pandemrix in Norway (letter) Mamelund SE, Storsæter J, Haugen IL, Ege MS, Bergsaker MR. BMJ Rapid Responses (for Garcia-Garcia et al., 339 (oct06_2) 3928).
(http://www.bmj.com/rapid-response/2011/11/02/clinical-efficiency-after-one-dose-pandemrix-norway)

7
Pandemic influenza A(H1N1)v: human to pig transmission in Norway? Hofshagen M, Gjerset B, Er C, Tarpai A, Brun E, Dannevig B, Bruheim T, Fostad IG, Iversen B, Hungnes O, Lium B.
Euro Surveill 2009; 14 pii: 19406. (http://www.ncbi.nlm.nih.gov/pubmed/19941789)

6
Sykdom forårsaket av nytt influensa A(H1N1) virus. Hauge SH, Dudman SG, Borgen K, Hungnes O, Brantsaeter A, Iversen B, Aavitsland P. Tidsskr Nor Legeforen 2009; 129: 1736-9. http://www.ncbi.nlm.nih.gov/pubmed/19756053)
5
Sales of oseltamivir in Norway prior to the emergence of oseltamivir resistant influenza A(H1N1) viruses in 2007-08.
Hauge SH, Blix HS, Borgen K, Hungnes O, Dudman SG, Aavitsland P. Virol J 2009; 6: 54. (http://www.ncbi.nlm.nih.gov/pubmed/19435505)

4
Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. Meijer A, Lackenby A, Hungnes O, Lina B, van-der-Werf S, Schweiger B, Opp M, Paget J, van-de-Kassteele J, Hay A, Zambon M; European Influenza Surveillance Scheme*. (* inkl Iversen B) Emerg Infect Dis 2009 15: 552-60. (http://www.ncbi.nlm.nih.gov/pubmed/19331731)

3
Interference between outbreaks of epidemic viruses: additional Norwegian observations. Anestad G, Vainio K, Hungnes O. Scand J Infect Dis 2009; 41: 381-2. (http://www.ncbi.nlm.nih.gov/pubmed/19308854)

2
Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08. Hauge SH, Dudman S, Borgen K, Lackenby A, Hungnes O. Emerg Infect Dis 2009; 15: 155-62. (http://www.ncbi.nlm.nih.gov/pubmed/19193257)

1
Start of the influenza season 2008-9 in Europe - increasing influenza activity moving from West to East dominated by A(H3N2). Goddard N, Zucs P, Ciancio B, Plata F, Hungnes O, Mazick A, Meijer A, Hay A, Daniels R, Nicoll A, Zambon M. Euro Surveill 2009; 14 pii: 19097. (http://www.ncbi.nlm.nih.gov/pubmed/19161722)